NovaBay Pharmaceuticals, Inc. — Director's Dealing 2021

Dec 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2021-11-30

Reporting Person: Kunin Jeffrey (President, DERMAdoctor, LLC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	Common Stock	P	30000	$0.46	Acquired	121133	Indirect

Footnotes

F1: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.